Patent · US Expired

Certain 1-azabicyclo[2.2.1]heptanes and 1-azabicyclo[2.2.2]octanes

US5541194A · kind A · utility

2Cited by
0References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 6, 1995
Grant dateJul 30, 1996
Priority date
Expiry dateJan 6, 2015

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D453/02
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Novel compounds of formula (I), processes for their preparation, and their use as pharmaceutical agents are described: ##STR1## in which p represents an integer of 2 to 4; r represents an integer of 1 or 2; s represents 0 or 1; and X represents a group ##STR2## in which A.sub.1 is oxygen or sulphur, one of A.sub.2 and A.sub.3 is CR.sub.1 and the other is nitrogen or CR.sub.2, or A.sub.2 is oxygen or sulphur, A.sub.1 is CH and A.sub.3 is CR.sub.1, where R.sub.1 and R.sub.2 are independently selected from hydrogen and C.sub.1-2 alkyl, with the proviso that when r is 2, R.sub.1 and R.sub.2 are hydrogen or methyl. The novel compounds of this invention may be used to treat or to prevent dementia in mammals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.